These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 15583519

  • 1. Duloxetine.
    Preskorn SH.
    J Psychiatr Pract; 2004 Nov; 10(6):375-85. PubMed ID: 15583519
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Duloxetine's role in the treatment of depression and associated painful physical symptoms.
    Wohlreich MM, Watkin JG, Gonzales JS.
    J Clin Psychiatry; 2004 Jul; 65(7):1018-9. PubMed ID: 15291696
    [No Abstract] [Full Text] [Related]

  • 4. Prescribing update: why choose duloxetine for depression?
    Tobin ML.
    Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011
    [No Abstract] [Full Text] [Related]

  • 5. [Mirtazapine-associated hepatotoxicity].
    Rodriguez-Pecci MS, Fuente-Aguado Jde L, Montero-Tinnirello J, Fernandez-Fernandez FJ.
    Med Clin (Barc); 2010 Nov 06; 135(13):625-6. PubMed ID: 19822332
    [No Abstract] [Full Text] [Related]

  • 6. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.
    Strawn JR, Whitsel R, Nandagopal JJ, Delbello MP.
    J Child Adolesc Psychopharmacol; 2011 Feb 06; 21(1):91-2. PubMed ID: 21309700
    [No Abstract] [Full Text] [Related]

  • 7. [If the general practitioner has to decide: what is the evidence for the selection of antidepressants?].
    Staudigl L, Becker T, Kösters M.
    Dtsch Med Wochenschr; 2014 Aug 06; 139(34-35):1727-30. PubMed ID: 25116024
    [Abstract] [Full Text] [Related]

  • 8. Severe urinary retention requiring urinary catheterization associated with combined treatment of depression with duloxetine and quetiapine.
    Wang SM, Lee KU, Jeon YW, Park EJ, Han SI.
    Psychiatry Clin Neurosci; 2013 Apr 06; 67(3):191. PubMed ID: 23581874
    [No Abstract] [Full Text] [Related]

  • 9. Rates of major malformations in infants following exposure to duloxetine during pregnancy: a preliminary report.
    Einarson A, Smart K, Vial T, Diav-Citrin O, Yates L, Stephens S, Pistelli A, Kennedy D, Taylor T, Panchaud A, Malm H, Koren G, Einarson TR.
    J Clin Psychiatry; 2012 Nov 06; 73(11):1471. PubMed ID: 23218163
    [No Abstract] [Full Text] [Related]

  • 10. Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis.
    Spielmans GI.
    Psychother Psychosom; 2008 Nov 06; 77(1):12-6. PubMed ID: 18087203
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine-induced life-threatening long QT syndrome.
    Štuhec M.
    Wien Klin Wochenschr; 2013 Mar 06; 125(5-6):165-6. PubMed ID: 23440523
    [No Abstract] [Full Text] [Related]

  • 12. [Duloxetine].
    Taéron C.
    Rev Infirm; 2010 Mar 06; (162):41-3. PubMed ID: 20701239
    [No Abstract] [Full Text] [Related]

  • 13. Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder.
    Lai CH.
    J Neuropsychiatry Clin Neurosci; 2011 Mar 06; 23(2):E42-3. PubMed ID: 21677225
    [No Abstract] [Full Text] [Related]

  • 14. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
    Mancini M, Perna G, Rossi A, Petralia A.
    Expert Opin Pharmacother; 2010 May 06; 11(7):1167-81. PubMed ID: 20402555
    [Abstract] [Full Text] [Related]

  • 15. Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs?
    Miller MC.
    Harv Ment Health Lett; 2004 Nov 06; 21(5):8. PubMed ID: 15556908
    [No Abstract] [Full Text] [Related]

  • 16. Answers to the most common questions about the hepatic safety profile of duloxetine.
    Wohlreich MM, Acharya N, Strombom I, Kuritzky L, Robinson M, Heinloth AN, Regev A, Wernicke JF.
    Postgrad Med; 2008 Jul 06; 120(2):111-8. PubMed ID: 18654076
    [Abstract] [Full Text] [Related]

  • 17. Somatic symptoms, depression, and antidepressant treatment.
    Fava M.
    J Clin Psychiatry; 2002 Apr 06; 63(4):305-7. PubMed ID: 12000203
    [No Abstract] [Full Text] [Related]

  • 18. Duloxetine: a review of its use in the treatment of major depressive disorder.
    Frampton JE, Plosker GL.
    CNS Drugs; 2007 Apr 06; 21(7):581-609. PubMed ID: 17579500
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effectiveness and tolerability of duloxetine in 2 different ethnic samples: a prospective observational cohort study.
    Collazos F, Ramos M, Qureshi A, Eiroa-Orosa FJ, Rodriguez A, Castells X, Ribases M, Valero S, Casas M.
    J Clin Psychopharmacol; 2013 Apr 06; 33(2):254-6. PubMed ID: 23422381
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.